Jazz Pharmaceuticals PLC <JAZZ.O>: Piper Sandler Raises Target Price to $310 From $301
JAZZ•Related News
ADTRAN Q2 Adjusted EPS USD 0.04 Vs. IBES Estimate USD 0.1
ADTN•
Replimune Group Inc: Leerink Partners raises to outperform from market perform; raises target price to $17.00 from $11.00
REPL•
JGB yields fall on lower oil prices; 10-year auction awaited
TLT•
Apple briefly removed Telegram from App Store after sexual abuse content violated guidelines
AAPL•
Bitmine joins Russell 1000 large-cap index
BMNR•